Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
about
HIV-Associated Pneumocystis PneumoniaClinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes.High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.Genetic analysis of multiple loci suggests that mutations in the Pneumocystis carinii f. sp. hominis dihydropteroate synthase gene arose independently in multiple strainsPneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia.Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiaeDihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, TanzaniaA Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-SulfamethoxazolePneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France.Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia.Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.Dihydropteroate synthase and novel dihydrofolate reductase gene mutations in strains of Pneumocystis jirovecii from South Africa.
P2860
Q22241388-7AD1E18A-5EF5-4248-A877-600E2FA5D405Q33856426-E98BD426-DF1E-42FC-9327-99A5C90DA53BQ33909311-B86F298B-8150-4547-953F-6383425FCF75Q33983414-BDF668CF-1D95-473D-A5F8-A5246BFF4846Q34445099-760A94C6-20A6-4137-8DD3-A9C8CFDA35D5Q35124449-9A8E6DDA-2D2C-46F6-8A92-A9A2823E8D15Q35124499-AC19F46B-B92B-44FE-8693-72DB78DF4549Q35129708-749DFE4B-066F-435F-AD81-CEF1453333B9Q35877664-B0F18A3C-F903-4BB6-A2C5-C1FAD9E9A0D9Q35880166-0FA0A794-DC5C-4DB8-9F34-C906BAA63018Q35880711-72751D6C-7BEE-4C11-9AEF-E2375674C26AQ35880756-5BF4C244-4EAD-4E87-9CFD-3AEA4506204EQ36570827-61986EC0-360F-4261-AEEA-49755FA583B2Q40450855-7A63CF66-2032-4751-AC89-1D681DFDF909Q42012011-75B04116-5675-4ABD-942E-974A31CD062B
P2860
Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Relationship between mutations ...... stance to sulfonamide therapy.
@ast
Relationship between mutations ...... stance to sulfonamide therapy.
@en
type
label
Relationship between mutations ...... stance to sulfonamide therapy.
@ast
Relationship between mutations ...... stance to sulfonamide therapy.
@en
prefLabel
Relationship between mutations ...... stance to sulfonamide therapy.
@ast
Relationship between mutations ...... stance to sulfonamide therapy.
@en
P2093
P2860
P1476
Relationship between mutations ...... istance to sulfonamide therapy
@en
P2093
H Sakashita
T Nakamura
T Takahashi
Y Nakamura
P2860
P304
P407
P577
2000-09-01T00:00:00Z